Arrowhead price target lowered to $24 from $27 at Bernstein
Bernstein lowered the firm’s price target on Arrowhead (ARWR) to $24 from $27 and keeps a Market Perform rating on the shares ...
Algert Global LLC Sells 3,480 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Algert Global LLC reduced its position in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 8.6% in ...
Citigroup Cuts Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target to $26.00
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) had its price target trimmed by Citigroup from $27.00 to $26.00 in a ...
Zacks.com on MSN22h
Sarepta Therapeutics Stock Surges 43% YTD: How to Play the Stock?
Shares of Sarepta Therapeutics SRPT have soared 43% year to date, significantly outperforming the industry’s 6.9% decline.
bovnews23h
What Factors Have Led to Arrowhead Pharmaceuticals Inc (ARWR) Stock Trading -34.35% Below Its 52-Week High?
Goldman has recently initiated Arrowhead Pharmaceuticals Inc (ARWR) stock to Neutral rating, as announced on June 5, 2024, according to Finviz. Earlier, on December 4, 2023, BofA Securities had ...